News
Prediction: These 2 Stocks Will Outperform the Market Through 2030
Equity markets can move every which way from one day to the next. The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Investors can cash in by putting their
Prediction: 2 Companies That Will Be Worth More Than AT&T 2 Years From Now
Three catalysts drove AT&T's (NYSE: T) stock price nearly 50% higher over the past two years.
Image source: Getty Images.
From 2024 to 2027, analysts expect AT&T's EPS to grow at a compound annual
VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility.
However, three Fool.com
Think It's Too Late to Buy Nvidia? Here's the Biggest Reason Why There's Still Time.
You could be forgiven if you thought that Nvidia (NASDAQ: NVDA) was a young company. It's rare for the stock of a mature business to suddenly take off after it's been on the market for a few years
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only if the company in question can reverse its fortunes.
Sometimes, corporations lag
Trump's Crypto Plan: Which Cryptocurrency Sectors Are Hot -- and Which Are Not
The new year started off with considerable fanfare for the cryptocurrency market. Under President Donald Trump's crypto plan, America was going to become "the crypto capital of the world." That
Why Ocular Therapeutix Was Bumping Higher This Week
The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's stock higher.
As of Friday morning before market open, the eye care
Why Summit Therapeutics Stock Was Winning This Week
A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock price pop. That upward lift was largely holding as of Friday before
Nasdaq Sell-Off: Why AMD Stock Is the AI Chip to Buy on the Dip
In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD), its business strategy, growth opportunities, potential risks, and why investors should not ignore this space stock.
*Stock prices
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable. The demand for healthcare products and services typically holds up very well
EQS-News: STRATEC RECEIVES VALIDATION OF ITS CLIMATE TARGETS FROM THE SCIENCE BASED TARGETS INITIATIVE (SBTi)
Nasdaq Correction: 3 No-Brainer Artificial Intelligence Stocks to Buy Right Now
The Nasdaq Composite (NASDAQINDEX: ^IXIC) is in correction territory as investors have been dumping growth stocks amid concerns related to tariffs, trade wars, and a potential slowdown in the
Got $5,000? These 3 High-Yielding Stocks Can Help Make the Most of Your Money
If you've got $5,000 that you can afford to invest in the stock market, you may want to consider putting that money into dividend stocks. Fears of an imminent recession are mounting, and dividend
2 Artificial Intelligence (AI) Stocks to Buy Before They Soar 82% and 124%, According to Certain Wall Street Analysts
The recent pullback in the stock market may have some investors on edge. The stocks selling off the most over the last couple of weeks are the same ones that led the stock market higher over the
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
Summit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation soaring 300% during that stretch. But things have slowed of late and since
AMD and Nvidia Stock Investors Just Got Amazing News From Oracle
In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and why investors should be cheering after Oracle's (NYSE: ORCL) earnings. To learn more, check out the short
Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q4 2024 Earnings CallMar 12, 2025, 8:00 a.m. ET
Operator
Source Fool.com
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for GLP-1 weight-loss drugs. Current runners-up Viking Therapeutics (NASDAQ:
3 Ways Tech Investors Can Navigate the Artificial Intelligence (AI) Sector Tumble
Investor interest in artificial intelligence (AI) stocks surged in 2024, but it looks to be cooling off in 2025. At the time of this writing, powerhouse chipmaker Nvidia (NASDAQ: NVDA) was down
Agenus (AGEN) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)Q4 2024 Earnings CallMar 11, 2025, 8:30 a.m. ET
Operator
Source Fool.com
Where Will Vertex Pharmaceuticals Be in 10 Years?
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since
Nasdaq Stock Market Correction: 2 Ultra-Cheap Stocks to Buy Right Now
The Nasdaq Composite (NASDAQINDEX: ^IXIC) is now 13% below its recent high, placing the tech-heavy index officially into correction territory. And while there are certainly good reasons why the
QuidelOrtho® Introduces Results Manager™ System
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) announces the availability of the QuidelOrtho® Results Manager™ System, an informatics solution designed to address the growing demands of
If I Could Buy Only 1 Growth Stock, This Would Be It
There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their hard-earned money into specific companies based on their preferences, risk